Release – Genco Shipping and Trading Limited Announces Second Quarter 2022 Conference Call and Webcast



Genco Shipping and Trading Limited Announces Second Quarter 2022 Conference Call and Webcast

Research, News, and Market Data on Genco Shipping & Trading

NEW YORK, July 18, 2022 (GLOBE NEWSWIRE) — Genco Shipping & Trading Limited (NYSE: GNK) announced today that it will hold a conference call to discuss the Company’s results for the second quarter of 2022 on Thursday, August 4, 2022 at 8:30 a.m. Eastern Time. The conference call will also be broadcast live over the Internet and include a slide presentation. The Company will issue financial results for the second quarter ended June 30, 2022 on Wednesday, August 3, 2022 after the close of market trading.

 

What:

Second Quarter 2022 Conference Call

 

 

 

 

When: 

Thursday, August 4, 2022 at 8:30 a.m. Eastern Time

 

 

 

 

Where:

There are two ways to access the call:

 

 

 

 

 

Dial-in: 646-828-8193 or 888-220-8451; Passcode: 7679501

 

 

 

 

 

Please dial in at least 10 minutes prior to 8:30 a.m. Eastern Time to ensure a prompt start to the call.

 

 

 

 

 

For live webcast and slide presentation: http://www.gencoshipping.com.

If you are unable to participate at this time, a replay of the call will be available for two weeks at 888-203-1112 or 719-457-0820. Enter the code 7679501 to access the audio replay. The webcast will also be archived on the Company’s website: http://www.gencoshipping.com.

About Genco Shipping &
Trading Limited

Genco Shipping & Trading Limited is a U.S. based drybulk ship owning company focused on the seaborne transportation of commodities globally. We provide a full-service logistics solution to our customers utilizing our in-house commercial operating platform, as we transport key cargoes such as iron ore, grain, steel products, bauxite, cement, nickel ore among other commodities along worldwide shipping routes. Our wholly owned high quality, modern fleet of dry cargo vessels consists of the larger Capesize (major bulk) and the medium-sized Ultramax and Supramax vessels (minor bulk) enabling us to carry a wide range of cargoes. We make capital expenditures from time to time in connection with vessel acquisitions. As of July 18, 2022, Genco Shipping & Trading Limited’s fleet consists of 17 Capesize, 15 Ultramax and 12 Supramax vessels with an aggregate capacity of approximately 4,636,000 dwt and an average age of 10.4 years.

CONTACT:
Apostolos Zafolias
Chief Financial Officer
Genco Shipping & Trading Limited
(646) 443-8550


Source: Genco Shipping & Trading Limited

Release – Kratos, USAF Complete Successful XQ-58A Valkyrie Skyborg Flight Series



Kratos, USAF Complete Successful XQ-58A Valkyrie Skyborg Flight Series

Research, News, and Market Data on Kratos Defense & Security Solutions

SAN DIEGO, 
July 18, 2022 (GLOBE NEWSWIRE) — 
Kratos Defense & Security Solutions, Inc. (NASDAQ: KTOS), a leading National Security Solutions provider and industry-leading provider of high-performance, jet-powered unmanned aerial systems, announced today that it has recently completed a successful series of flights with two production XQ-58A Valkyrie aircraft for the Skyborg Program. The program team includes the 
U.S. Air Force (USAF) Fighters and 
Advanced Aircraft Directorate
Air Force Research Laboratory (AFRL), USAF 40th 
Flight Test Squadron (FLTS), USAF 46th 
Test Squadron
, and Kratos.

Steve Fendley,
President of the Kratos Unmanned Systems Division
, said, “The continued evolution and demonstration of the USAF Skyborg system is charting the course for the range of tactical applications Skyborg is intended to address and inform. These most recent Skyborg flights, with production Valkyrie aircraft being delivered on the Skyborg contract, illustrate the benefits and utility of these uncrewed systems while informing the operational concepts and Concepts of Employment (CONEMPS). The entire Kratos team is excited to be a part of this game-changing application space for military uncrewed aircraft systems.”

The XQ-58A Valkyrie was initially developed in cooperation with AFRL on the Low Cost Attritable Strike Demonstrator (LCASD) Program with multiple follow-on programs and projects for several customers and applications. These multiple program applications continue with the Skyborg Program, as well as several others related to production, specific mission applications, and operational development of the XQ-58A family of affordable, high speed, tactical UAVs.

About Kratos
Defense & Security Solutions

Kratos Defense & Security Solutions, Inc. (NASDAQ:KTOS) develops and fields transformative, affordable technology, platforms and systems for United States National Security related customers, allies, and commercial enterprises. Kratos is changing the way breakthrough technology for these industries are rapidly brought to market through proven commercial and venture capital backed approaches, including proactive research, and streamlined development processes. Kratos specializes in unmanned systems, satellite communications, cyber security/warfare, microwave electronics, missile defense, hypersonic systems, small to mid-sized jet engines and technology, training, and combat systems. For more information go to www.KratosDefense.com.

Notice Regarding Forward-Looking Statements
Certain statements in this press release may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are made on the basis of the current beliefs, expectations, and assumptions of the management of Kratos and are subject to significant risks and uncertainty. Investors are cautioned not to place undue reliance on any such forward-looking statements. All such forward-looking statements speak only as of the date they are made, and Kratos undertakes no obligation to update or revise these statements, whether as a result of new information, future events or otherwise. Although Kratos believes that the expectations reflected in these forward-looking statements are reasonable, these statements involve many risks and uncertainties that may cause actual results to differ materially from what may be expressed or implied in these forward-looking statements. For a further discussion of risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to the business of Kratos in general, see the risk disclosures in the Annual Report on Form 10-K of Kratos for the year ended 
December 30, 2020, and in subsequent reports on Forms 10-Q and 8-K and other filings made with the 
SEC by Kratos.

Press Contact: Yolanda White 858-812-7302 Direct

Investor Information:
877-934-4687

investor@kratosdefense.com

 


Release – Alliance Resource Partners, L.P. Announces Second Quarter 2022 Earnings Conference Call



Alliance Resource Partners, L.P. Announces Second Quarter 2022 Earnings Conference Call

Research, News, and Market Data on Alliance Resource Partners

TULSA, Okla.–(BUSINESS WIRE)– Alliance Resource Partners, L.P. (NASDAQ: ARLP) will report its second quarter 2022 financial results before the market opens on Monday, August 1, 2022. Alliance management will discuss these results during a conference call beginning at 10:00 a.m. Eastern that same day.

To participate in the conference call, dial (877) 407-0784 and request to be connected to the Alliance Resource Partners, L.P. earnings conference call. International callers should dial (201) 689-8560 and request to be connected to the same call. Investors may also listen to the call via the “investor information” section of ARLP’s website at http://www.arlp.com.

An audio replay of the conference call will be available for approximately one week. To access the audio replay, dial U.S. Toll Free (844) 512-2921; International Toll (412) 317-6671 and request to be connected to replay using access code 13731312.

About Alliance
Resource Partners, L.P.

ARLP is a diversified energy company that is currently the largest coal producer in the Eastern United States. ARLP also generates operating and royalty income from mineral interests it owns in strategic coal and oil & gas producing regions in the United States. In addition, ARLP is positioning itself as an energy provider for the future by leveraging its core technology and operating competencies to make strategic investments in the fast-growing energy and infrastructure transition.

News, unit prices and additional information about ARLP, including filings with the Securities and Exchange Commission (“SEC”), are available at http://www.arlp.com. For more information, contact the investor relations department of ARLP at (918) 295-7674 or via e-mail at investorrelations@arlp.com.

Brian L. Cantrell
Alliance Resource Partners, L.P.
(918) 295-7673

 


Filament Health (FLHLF) – Patient Dosing Has Begun in Phase I Psilocin Trial, Seventh Patent Issued, and New Funds Raised

Monday, July 18, 2022

Filament Health (FLHLF)
Patient Dosing Has Begun in Phase I Psilocin Trial, Seventh Patent Issued, and New Funds Raised

Robert LeBoyer, Vice President, Research Analyst, Life Sciences , Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Recent Progress Has Been Made In Several Areas.  Filament Health has announced the dosing of the first patient in the Phase 1 trial testing orally administered psilocybin against its two formulations of psilocin.  This trial will compare psilocybin with two proprietary formulations of psilocin, its active metabolite.  The company has also announced the issuance of its seventh patent and raised $2.5 million through a Private Placement.

The trial is being conducted at the University of San Francisco’s Translational Psychedelic Research Program (TrPR), a collaboration of academic scientists and clinicians from several medical specialties that are exploring the use of psychedelic compounds as therapeutics.  The clinical trial consists of three dosing arms, with patients receiving the orally administered formulation of psilocybin, PEX010, the orally administered formulation of psilocin, PEX020, or the sublingual formulation, PEX030.  The study will compare the physiological and psychological effects of the three formulations, dosing consistency, and the related side-effects….

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

MustGrow Biologics Corp. (MGROF) – A Healthier Way to Grow and Preserve the Food Supply

Monday, July 18, 2022

MustGrow Biologics Corp. (MGROF)
A Healthier Way to Grow and Preserve the Food Supply

Joe Gomes, Senior Research Analyst, Noble Capital Markets, Inc.

Joshua Zoepfel, Research Associate, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Initiating Coverage. We are initiating coverage of MustGrow Biologics Corp. with a Market Perform rating. MustGrow is an agtech company with a natural, organic technology platform that has proved highly efficacious in controlling microbial diseases, pests, and weeds. The Company ‘s patented technology has undergone over 110 independent studies confirming its abilities.

A Greener Way. MustGrow harnesses the mustard seed’s natural defense mechanism as the base for its product. MustGrow’s active ingredient possesses several benefits including sustainability, positive soil health, and minor ecological impact. The product has the potential to be priced competitively with conventional alternatives.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Release – Voyager Digital Provides Update on Listing of its Shares

 



Voyager Digital Provides Update on Listing of its Shares

Research, News, and Market Data on Voyager Digital

NEW YORK, July 15, 2022 /CNW/ – Voyager Digital Ltd. (“Voyager” or the “Company”) (TSX: VOYG) (OTC: VYGVQ) (FRA: UCD) today announced that common shares of the Company have resumed trading on the OTC Pink Sheets under the new ticker symbol “VYGVQ.” Due to the Company’s July 5, 2022, bankruptcy filing, Voyager no longer qualifies to trade on OTCQX International.  

Trading of the Company’s common shares on the OTC was initially halted on July 7, 2022, when Voyager notified the Toronto Stock Exchange (the “TSX”) that the Company would voluntarily delist its common shares from the TSX. The Company took this action in response to a notification from the TSX that the TSX would review the eligibility of the Company’s common shares for continued listing on TSX as a result of the Company and its main operating subsidiaries filing voluntary petitions for reorganization under Chapter 11 in the U.S. Bankruptcy Court of the Southern District of New York.

The resumption of trading on the OTC Pink Sheets and the voluntary delisting of the Company’s common shares on the TSX have no impact on the Company’s continued business operations.

Additional information regarding the ticker symbol change can be found at www.otcmarkets.com/stock/VYGVQ/security.

Parties with questions about the chapter 11 process may contact the Company’s Claims Agent, Stretto, at +1 (855) 473-8665 (toll-free in the U.S.) or +1 (949) 271-6507 (for parties outside the U.S.). They have also set up a website at 
http://cases.stretto.com/Voyager, which includes court documents and other information.

About Voyager Digital
Ltd.

Voyager Digital Ltd.’s (TSX: VOYG) (OTC Pink: VYGVQ) (FRA: UCD) US subsidiary, Voyager Digital, LLC, is a cryptocurrency platform in the United States founded in 2018 to bring choice, transparency, and cost-efficiency to the marketplace. Voyager offers a secure way to trade over 100 different crypto assets using its easy-to-use mobile application. Through its subsidiary Coinify ApS, Voyager provides crypto payment solutions for both consumers and merchants around the globe. To learn more about the company, please visit https://www.investvoyager.com.

Forward
Looking Statements

Certain information in this press release, including, but not limited to, statements regarding the restructuring process, the restructuring Plan, available remedies for recovery from 3AC, intended filings as part of the restructuring process, resumption of account access, return of value to customers, the ability of Voyager to continue as a going concern, exploration of strategic alternatives, discussions with third parties in respect of strategic alternatives and the results of those discussions, the temporary nature of the suspension of the platform, future growth and performance of the business, the exploration of strategic alternatives, future adoption of digital assets, anticipated trends and challenges in our business and industry, the regulation of digital assets offerings, the impact of the 3AC default on the Company, the Company’s liquidity and ability to satisfy customer orders and withdrawals and the Company’s anticipated results may constitute forward looking information (collectively, forward-looking statements), which can be identified by the use of terms such as “may,” “will,” “should,” “expect,” “anticipate,” “project,” “estimate,” “intend,” “continue” or “believe” (or the negatives) or other similar variations. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause Voyager’s actual results, performance or achievements to be materially different from any of its future results, performance or achievements expressed or implied by forward-looking statements. Moreover, we operate in a very competitive and rapidly changing environment. New risks emerge from time to time. It is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements we may make. In light of these risks, uncertainties, and assumptions, the future events and trends discussed in this press release may not occur and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements. It is uncertain as to the timing or results of the restructuring process or the terms of the final restructuring plan, when account access will resume, the value to be returned to customers, what amount Voyager will be able to recover from 3AC for non-payment or the legal remedies available to Voyager in connection with such non-payment or the impact on the future business, cash flows, liquidity and prospects of Voyager as a result of 3AC’s non-payment. Forward looking statements are subject to the risk that the global economy, industry, or the Company’s businesses and investments do not perform as anticipated, that revenue or expenses estimates may not be met or may be materially less or more than those anticipated, that parties to whom the Company lends assets are able to repay such loans in full and in a timely manner, that trading momentum does not continue or the demand for trading solutions declines, customer acquisition does not increase as planned, product and international expansion do not occur as planned, risks of compliance with laws and regulations that currently apply or become applicable to the business and those other risks contained in the Company’s public filings, including in its Management Discussion and Analysis and its Annual Information Form (AIF). Factors that could cause actual results of the Company and its businesses to differ materially from those described in such forward-looking statements include, but are not limited to, the results of the restructuring process and the terms of the restructuring plan, if such a plan is ultimately agreed to, the results from the exploration of strategic alternatives, the inability to resume trading, deposits, withdrawals and rewards on the platform in a timely manner, an inability to drawdown under the credit facility or access other sources of financing, an increase in customer demands for withdrawals from the platform, any insolvency or similar proceedings with respect to 3AC, our ability to find a strategic alternative, a decline in the digital asset market or general economic conditions; changes in laws or approaches to regulation, the failure or delay in the adoption of digital assets and the blockchain ecosystem by institutions; changes in the volatility of crypto currency, changes in demand for Bitcoin and Ethereum, changes in the status or classification of cryptocurrency assets, cybersecurity breaches, a delay or failure in developing infrastructure for the trading businesses or achieving mandates and gaining traction; failure to grow assets under management, an adverse development with respect to an issuer or party to the transaction or failure to obtain a required regulatory approval. Readers are cautioned that Assets on Platform and trading volumes fluctuate and may increase and decrease from time to time and that such fluctuations are beyond the Company’s control. Forward-looking statements, past and present performance and trends are not guarantees of future performance, accordingly, you should not put undue reliance on forward-looking statements, current or past performance, or current or past trends. Information identifying assumptions, risks, and uncertainties relating to the Company are contained in its filings with the Canadian securities regulators available at www.sedar.com. The forward-looking statements in this press release are applicable only as of the date of this release or as of the date specified in the relevant forward-looking statement and the Company undertakes no obligation to update any forward-looking statement to reflect events or circumstances after that date or to reflect the occurrence of unanticipated events, except as required by law. The Company assumes no obligation to provide operational updates, except as required by law. If the Company does update one or more forward-looking statements, no inference should be drawn that it will make additional updates with respect to those or other forward-looking statements, unless required by law. Readers are cautioned that past performance is not indicative of future performance. There is no assurance that the funds available under the loan agreement will be available or, even if available will, together with any other assets of Voyager be sufficient to safeguard assets.

The TSX
has not approved or disapproved of the information contained herein.

Press
Contacts

Voyager
Digital, Ltd.

Voyager Public Relations Team
pr@investvoyager.com

SOURCE Voyager Digital Ltd.


SEC Issues Cautionary Statement to Investors



Image Credit: Fernando Arcos (Pexels)


Newly Concocted Securities Draws a Warning Statement from Director at SEC

 A new form of ETF with its own risk/reward attributes is about to converge on the markets. The exchange-traded, derivative-based security will, over time, provide investors a new breed of investment vehicle to gain exposure to price changes in an underlying stock. At the Securities and Exchange Commission, Lori Schock, the Director of Investor Education and Advocacy, put out a statement last week on what the Commission is calling Single-Stock Levered and/ Inverse ETFs

For the benefit of Channelchek members,  I have reposted the full contents of the SEC statement below.     We know our readers want to keep up to date on all that could impact small and microcap stocks, the broader financial markets, and their investments. This new breed of offering has the power to affect each of them.  

Paul Hoffman

Managing Editor, Channelchek

Statement on
Single-Stock Levered and/or Inverse ETFs

Lori J. Schock, Director, Securities and Exchange Commission

Today and in the coming weeks, a new type of complex exchange-traded product will become available to investors in the U.S.: single-stock levered and/or inverse exchange-traded funds. For years, the Office of Investor Education and Advocacy, staff in other Divisions and Offices, and a number of Commissioners have warned that complex products present several risks to investors. These new products are no exception, as they provide levered and/or inverse exposure to a single security, which can present risks for investors.

Holding a levered and/or inverse single-stock ETF is not the same as holding the underlying stock, a traditional ETF, or even a non-single stock levered and/or inverse ETF. It is riskier for several reasons. Importantly, like many other complex exchange-traded products, levered and/or inverse single-stock ETFs aim to provide returns over extremely short time periods (in some cases even a single day). New risks may emerge for investors who hold these products for longer than that. Investors should be aware that if they were to hold these funds for longer than a day, the performance of these funds may differ significantly from the levered and/or inverse performance of the underlying stock during the same period of time.

Additionally, unlike traditional ETFs, or even other levered and/or inverse ETFs, these levered and/or inverse single-stock ETFs track the price of a single stock rather than an index, eliminating the benefits of diversification. Because levered single-stock ETFs in particular amplify the effect of price movements of the underlying individual stocks, investors holding these funds will experience even greater volatility and risk than investors who hold the underlying stock itself.

Though these products will be listed and traded on an exchange, they are not right for every investor. Levered and/or inverse single-stock ETFs pose risks that are unique and complex. We encourage all investors to consider these risks carefully before deciding to invest in levered and/or inverse single-stock ETFs.

Suggested Content



Leveraged and Inverse ETF Do’s and Mostly Don’ts



Market Leverage Swings Both Ways




The Beveridge Curve Indicates Aggressive Fed Action Shouldn’t be Feared



Biotech Stocks Outperformance Factors – Will they Continue?


Source

https://www.sec.gov/news/statement/schock-statement-single-stock-levered-and-or-inverse-etfs-071122

Stay up to date. Follow us:

 

Thoughts on Crypto Rules Get Further Defined by SEC



Image: Yahoo News (July 14, 2022)


SEC Claims Authority Over Cryptos and Says Revised Securities Law Could Apply

During an interview this week, Securities and Exchange Commission (SEC) Chairman Gary Gensler covered several cryptocurrency-related topics and shared for the first time how the Securities regulator may define its authority and deal with a myriad of digital-asset issues and concerns. Gensler assured the interviewer and listeners that the regulator does have broad enough powers from Congress to institute changes to protect the public involved in the asset class. His statement about authority seems to give a nod to a recent Supreme
Court ruling
related to the FDA but impacting all agencies created through Congressional legislation.

During the interview, which was streamed on Yahoo Finance,  Gensler said that the Commission may exempt parts of securities law in order to help companies involved in cryptocurrency fall into compliance. He referred to other examples where this has been done. The Chairman insisted that there are many non-compliant companies offering crypto, which he views
as securities
. Although the SEC Chairman views the digital assets as securities, other regulators, such as the Commodities Futures Exchange (CFTC) have treated them differently. The two oversight bodies have been at odds over cryptocurrency since even before Chairman Gensler was appointed.

Security and Exchange Commission Oversight


Source: SEC.gov

The SEC has targeted several crypto companies, accusing them of conducting unregistered securities sales. The most high-profile case is with fintech firm Ripple, which is to be settled soon. Victory for Ripple would set a precedent that would almost certainly buoy the beaten-down cryptocurrency sector.

In March, the Executive branch issued an Executive Order for federal agencies to “play a leading
role
in international engagement and global governance of digital assets consistent with democratic values and U.S. global competitiveness.”

Very little headway has been made since then and crypto legislation is unlikely to be passed this year. It is an election year, and digital assets are more of a political issue than they may seem. Several politicians and bankers are proponents of fostering the innovation that could make the country a fintech hub, which is what the industry advocates want. And others look for a heavy-handed crackdown on the U.S.

Paul Hoffman

Managing Editor, Channelchek

Suggested Content



Digital Currencies Gain Value on Biden Executive Order



Cryptocurrency Executive Order from White House Could Come Before President’s Day




What is the Fed’s Position on Crypto, Stablecoin, and CBDCs?



US Inflation is a Big Ship to Steer


Sources

https://www.youtube.com/watch?v=Gy2IF_og2Nw

https://home.treasury.gov/news/press-releases/jy0854

https://finance.yahoo.com/news/sec-chair-mulls-waiving-crypto-025531991.html?.tsrc=fin-srch

https://www.whitehouse.gov/briefing-room/statements-releases/2022/03/09/fact-sheet-president-biden-to-sign-executive-order-on-ensuring-responsible-innovation-in-digital-assets/

Stay up to date. Follow us:

 

Biotech Stocks Outperformance Factors – Will they Continue?



Image Credit: CDC (Pexels)


Is Biotech’s Outperformance Reaching a New Stage of Development?

The biotech investment sector has always been its own market, very distinct from other sectors. So it was no surprise that when most sectors turned slowly upward after the pandemic-inspired crash, Biotech (XBI) rose 164%, exceeding the overall market (SPY) performance by triple digits. Then, about 11 months from biotech’s launch to the stratosphere, it took its own path downward even though the overall market continued upward for another 11 months. In recent weeks the overall market has been trading sideways after hitting a YTD low on June 16th. Over the same short period, the biotech sector has gained double-digits.

This past June 13th, the SPDR biotech ETF formed a technical double bottom (May 11/Jun 13) and has since risen near 30% in one month’s time. It was obvious what drove these stocks higher during the pandemic. The enthusiasm for modern medicine was at a peak with the news on most people’s minds each day. But what is driving this sector’s heights now, and will it continue? 

What’s Happening

Since the start of the current upturn on June 13, the XBI is up 28.4%, after biotech’s period of being among the most beaten down sectors most of the year. The XBI would still have to rise by another 25% to reach breakeven on the year. Some investors think that its slide was overdone and are now allocating more to the biotech sector.


Source: Koyfin

In a note on Thursday (July 14), Piper Sandler analyst Christopher Rayment said $1.1 billion in net new money, the second-highest total this year, flowed into funds focused on healthcare and biotech for the week ended July 6. One catalyst for the increase could be reports from The Wall Street Journal that Merck (MRK) may be involved in a $40 billion purchase of the biotech Seagen (SGEN), a cancer-focused drugmaker. Also, the FDA approval scientists are less bogged down with pandemic-related entries and can begin to move forward, business as usual, with their approval studies.

The Seagen deal could further increase investor interest in the sector as the Merck name will likely keep it in the headlines. And perhaps it is time that biotechs regain attention, they are far cheaper than they have been in years.

Recent biotech deals receiving less attention are:

  • La Jolla Pharmaceuticals (LJPC) on July 11, acquired by Innoviva at an 84% premium
  • Epizyme (EPZM) on June 27, acquired by Ipsen at a 53% premium
  • F Star Therapeutics (FSTX) on June 23, acquired by invoXPharma at a 122% premium
  • TherapeuticsMD (TXMD)on May 31, acquired by EW Healthcare Partners at a 367% premium

The pace of acquisitions, just past the halfway point of the year, is running above the previous four years. The category impacted most often in each of the five periods is oncology.


* The data is limited to deals valued at a minimum of $50 million upfront. Total consideration can reflect both cash and equity offered upfront in exchange for the acquired company’s shares, but deals in which the upfront payment was not specified, or was less than $50 million, are not included.

Since the June 13 turn upward, other companies in this space that generated double-digit returns for shareholders, near or above XBI are:

  • Imugene (IUGNF) up 53.7%
  • PDS Biotechnology (PDSB) up 33.4%
  • Ocugen (OCGN) up 27.5%
  • Lineage Cell Therapeutics (LCTX)up 19.2%


Source: Koyfin

Take Away

The biotech sector is not highly correlated with the overall market. During periods of market weakness, it is a good idea to look at less-correlated sectors to determine if there is relative strength and opportunity.

Biotech investors often look to a company’s pipeline to determine where it may be in developmental stages to determine if a valuation-changing breakthrough could be near. Astute investors also try to find gains by investing in companies with the potential of being acquired. The current scenario where huge pharmaceutical companies are sitting with cash at very high valuations, and biotech firms have been beaten down, creates a recipe for increased mergers and acquisitions. Also, many biotechs that rely on capital raises to get them through the long R&D or approval stage find it more difficult to raise capital when their stock trades very low. These companies with a worthwhile pipeline are now very attractive to large better-capitalized companies. For the small biotech companies, they may be more willing than ever to be acquired to keep their treatment development on track.

In the business of drug development, deals are as important as medical breakthroughs. Many of today’s most influential medicines might not have made it to the finish line without a timely partnership or acquisition.

Paul Hoffman

Managing Editor, Channelchek

Suggested Content



Lineage Cell Therapeutics (LCTX) NobleCon18 Presentation Rebroadcast



Ocugen (OCGN) NobleCon18 Presentation Rebroadcast




Genprex (GNPX) NobleCon18 Presentation Rebroadcast



Pasithea Therapeutics (KTTA) NobleCon18 Presentation Rebroadcast


Sources

https://app.koyfin.com/share/dd2a65e582

https://www.thestreet.com/investing/cathie-wood-ark-buys-biotech

https://www.wsj.com/articles/merck-is-in-advanced-talks-to-buy-seagen-11657160827

https://www.wsj.com/articles/merck-eyes-purchase-of-biotech-seagen-11655476223?mod=article_inlin

https://www.pipersandler.com/2col.aspx?id=7&analystid=2284

Stay up to date. Follow us:

 

Release – Noble Capital Markets Initiates Equity Research Coverage on Direct Digital Holdings



Noble Capital Markets Initiates Equity Research Coverage on Direct Digital Holdings

Research, News, and Market Data on Direct Digital Holdings

HOUSTON, July 15, 2022 /PRNewswire/ — Direct Digital Holdings (Nasdaq: DRCT) (“Direct Digital”), a leading advertising and marketing technology platform, is pleased to announce that Noble Capital Markets has initiated company-sponsored equity research coverage on the Company. The full report by Noble Capital Markets Senior Research Analyst Michael Kupinski, as well as news and advanced market data on Direct Digital Holdings, is available on Channelchek.

About Direct Digital
Holdings

Direct Digital Holdings (Nasdaq: DRCT) brings state-of-the-art sell- and buy-side advertising platforms together under one umbrella company. The holding group’s sell-side platform Colossus SSP offers advertisers of all sizes extensive reach within general market and multicultural media properties. Its operating companies Huddled Masses and Orange142 deliver significant ROI for middle market advertisers by providing data-optimized programmatic solutions at scale for businesses in sectors that range from energy to healthcare and travel to financial services. Direct Digital Holdings’ sell- and buy-side solutions manage approximately 70,000 clients monthly, generating over 90 billion impressions per month across display, CTV, in-app and other media channels. The company has been named a top minority-owned business by The Houston Business Journal (“HBJ”).

About Noble Capital
Markets

Noble Capital Markets, Inc. was incorporated in 1984 as a full-service SEC / FINRA registered broker-dealer, dedicated exclusively to serving underfollowed small / microcap companies through investment banking, wealth management, trading & execution, and equity research activities. Over the past 37 years, Noble has raised billions of dollars for these companies and published more than 45,000 equity research reports. www.noblecapitalmarkets.com email: contact@noblecapitalmarkets.com

About Channelchek

Channelchek (.com) is a comprehensive investor-centric portal – featuring more than 6,000 emerging growth companies – that provides advanced market data, independent research, balanced news, video webcasts, exclusive c-suite interviews and access to virtual road shows. The site is available to the public at every level without cost or obligation. Research on Channelchek is provided by Noble Capital Markets, Inc., an SEC / FINRA registered broker-dealer since 1984. 
www.channelchek.com email: contact@channelchek.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/noble-capital-markets-initiates-equity-research-coverage-on-direct-digital-holdings-301587228.html

SOURCE Direct Digital Holdings

 


TAAL Distributed Information Technologies (TAALF) – Getting More Machines

Friday, July 15, 2022

TAAL Distributed Information Technologies (TAALF)
Getting More Machines

TAAL Distributed Information Technologies Inc. delivers value-added blockchain services, providing professional-grade, highly scalable blockchain infrastructure and transactional platforms to support businesses building solutions and applications upon the BitcoinSV platform, and developing, operating, and managing distributed computing systems for enterprise users.

Joe Gomes, Senior Research Analyst, Noble Capital Markets, Inc.

Joshua Zoepfel, Research Associate, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

More Machines. On Wednesday, TAAL’s management announced that the Company will be acquiring 968 Bitmain S19J Pro machines that will be housed in a New Mexico facility and use immersion cooling to optimize performance. The majority of the facility will be powered by non-carbon emitting solar energy, and the machines will immediately begin to hash upon agreement inception. For processing power, the machines will give TAAL an additional 100 petahash/second.

New Brunswick Facility. The New Mexico facility is acting as a test bed ahead of final design plans for the Company’s flagship 50MW site in Grand Falls, New Brunswick, which is due to come online in 2023. Recall, the Company closed on the 60,000 square foot facility in December of 2021 and is expected to have a mining capacity of 2 exahash alone. Once online, we expect the facility to be a major impact towards the Company’s top line and be a big leap for TAAL moving forward….

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Tokens.com Corp. (SMURF) – Another Play-to-Earn Acquisition

Friday, July 15, 2022

Tokens.com Corp. (SMURF)
Another Play-to-Earn Acquisition

Tokens.com Corp is a publicly traded company that invests in Web3 assets and businesses focused on the Metaverse, NFTs, DeFi, and gaming based digital assets. Tokens.com is the majority owner of Metaverse Group, one of the world’s first virtual real estate companies. Hulk Labs, a wholly-owned Tokens.com subsidiary, focuses on investing in play-to-earn revenue generating gaming tokens and NFTs. Additionally, Tokens.com owns and stakes crypto assets to earn additional tokens. Through its growing digital assets and NFTs, Tokens.com provides public market investors with a simple and secure way to gain exposure to Web3.

Joe Gomes, Senior Research Analyst, Noble Capital Markets, Inc.

Joshua Zoepfel, Research Associate, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

A New Acquisition. Tokens.com management announced yesterday the acquisition of play-to-earn company Playte Group, which will be integrated into Tokens.com subsidiary, Hulk Labs. In the acquisition, the Company will be issuing one million shares, or around CAD$400,000, with the Playte team being eligible for additional shares based on meeting various performance-based milestones.

What is Playte Group? Playte Group is a development entity that builds and manages play-to-earn ecosystems, along with building tools in play-to-earn games such as Axie Infinity. Playte Group also is in the process of building a network that consists of 1,000+ players in Africa, primarily in Tanzania and the Democratic Republic of the Congo (DRC).

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Garibaldi Resources Corp (GGIFF) – Drilling Expected to Commence Shortly

Friday, July 15, 2022

Garibaldi Resources Corp (GGIFF)
Drilling Expected to Commence Shortly

Garibaldi Resources Corp. is an active Canadian-based junior exploration company focused on creating shareholder value through discoveries and strategic development of its assets in some of the most prolific mining regions in British Columbia and Mexico.

Mark Reichman, Senior Research Analyst, Natural Resources, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

A bounty of high value metals. Within Garibaldi’s Eskay Creek Claim Group, the E&L Nickel Mountain and Casper projects are in the heart of Northwest British Columbia’s Golden Triangle, an area rich in base and precious metals. E&L Nickel Mountain is a high-grade nickel-copper-platinum group element and gold magmatic sulfide deposit, while the Casper discovery represents a gold-bearing quartz-sulfide system. Garibaldi Resources is unique because it offers exposure to high value metals that play a critical role in clean air and battery technologies, along with precious metals.

Drilling to commence shortly. Following up on recent geophysical surveys that provided property-wide targets for magmatic and hydrothermal base and precious metal mineralization with high discovery potential, we expect drilling to commence shortly and entail up to 10 drill holes at E&L, 2 to 3 drill holes at the B1 target, along with drilling at Palm Springs and Casper. While lead times for assay results remains extended, we think management will be able to draw meaningful conclusions prior to receiving assays….

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision.